GoodRx Holdings, Inc. Payments of Stock Issuance Costs
GoodRx Holdings, Inc. (GDRX) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-01
- GoodRx Holdings, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- GoodRx Holdings, Inc. payments of stock issuance costs for the quarter ending 2020-12-31 was $3.10M.
- GoodRx Holdings, Inc. payments of stock issuance costs for fiscal 2022 was $0.00.
- GoodRx Holdings, Inc. payments of stock issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- GoodRx Holdings, Inc. payments of stock issuance costs for fiscal 2020 was $4.94M.
- GoodRx Holdings, Inc. payments of stock issuance costs for fiscal 2019 was $0.00.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.94M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $1.84M 10-Q · filed 2021-11-12 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |